Disclosures for "Clinical Diagnostic Laboratory Experience With Alzheimer’s Disease Blood Biomarker Testing: Insights Into Healthcare Provider Test Utilization and Patient Results"
-
Dr. Aurora has received personal compensation for serving as an employee of C2N Diagnostics. Dr. Aurora has stock in Impel Neurpharma.
-
Ms. Coppinger has received personal compensation for serving as an employee of C2N Diagnostics, LLC. Ms. Coppinger has stock in C2N Diagnostics, LLC.
-
Dr. Ray has received personal compensation for serving as an employee of C2N Diagnostics.
-
Dr. Braunstein has received personal compensation for serving as an employee of C2N Diagnostics. Dr. Braunstein has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for C2N Diagnositcs.
-
Author has nothing to disclose
-
Dr. West has received personal compensation for serving as an employee of C2N Diagnostics, LLC. Dr. West has stock in C2N Diagnostics, LLC.